Diffuse expression of p16 (> 90% of tumor cells) is very rare in primary mucinous tumors - the largest study focusing on this issue reported diffuse p16 positivity in 5.7% of primary ovarian mucinous carcinomas [131]. This evidence concerns the gene CDKN2A and mucinous neoplasm.